In the BioHarmony Drug Report Database

"Preview" Icon

Procarbazine

Matulane (procarbazine) is a small molecule pharmaceutical. Procarbazine was first approved as Matulane on 1982-01-01. It is used to treat brain neoplasms, hodgkin disease, lung neoplasms, melanoma, and multiple myeloma amongst others in the USA.

 

Trade Name

 

Matulane
 

Common Name

 

procarbazine
 

ChEMBL ID

 

CHEMBL1321
 

Indication

 

brain neoplasms, hodgkin disease, lung neoplasms, melanoma, multiple myeloma, non-hodgkin lymphoma
 

Drug Class

 

Image (chem structure or protein)

Procarbazine structure rendering